Table 2

 Clinical characteristics, management, and outcome of patients from the two institutions

Age (years)SexCo-morbidityValve involved, clinical presentationComplicationsSurgeryOutcome
*Reported previously in reference 24.
Acute, duration of symptoms <30 days; AMI, acute myocardial infarction; CHF, congestive heart failure; chronic, duration of symptoms >30 days; CPB, cardiopulmonary bypass; early onset, symptoms <12 months after surgical manipulation; ET, external traction; late onset, symptoms >12 months after surgical manipulation; F, female; M, male; Veg, vegetation.
77FLiver cirrhosis, Le Veen shuntNative mitral, acute, no echocardiographyMeningitis, CHFNoDied in hospital
82FIschaemic heart diseaseNative atrial, acute, veg 12 mmAMI, CHF, periannular abscessYesDied in hospital
68*FDDD pacemaker 7 years, battery replacement 1 year previouslyPacemaker lead veg 22 mm, early onsetNoneYesAlive; relapse 1 year after initial medical treatment: delayed surgery (ET)
66MDDD pacemaker 10 years previouslyPacemaker lead veg 23 mm, late onsetShockYes (CPB)Died in hospital
78MDDD pacemaker 5 years, battery replacement 4 months previously, chronic pocket infectionPacemaker lead veg 10 mm, early onsetNoneYes (ET)Alive
70MAortic valve surgeryAortic bioprosthesis, acute, veg 8 mmPeriannular abscess, shockYesDied in hospital
77MAortic valve surgeryAortic bioprosthesis, chronic, no vegetationPeriannular abscessNoAlive
43FCongenital pulmonary stenosisNative pulmonary, acute, no vegNoneNoAlive
37MNoneNative aortic, acute, veg, no vegPeripheral embolism, periannular abscess, CHF, shockYesDied in hospital
63MVVI pacemaker 15 years, battery replacement 2 months previously, chronic pocket infectionPacemaker lead veg 8 mm, early onsetNoneYes (ET)Alive